Skip to content

Clinical trials

Completed Thrombocytopenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Status: Completed Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20101
20132
20142
20152
20162
20184
20195
20203
20211
20221
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University4
Abbott Medical Devices2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Eisai Inc.2
Institute of Hematology & Blood Diseases Hospital, China2
Novartis Pharmaceuticals2
The First Affiliated Hospital of Soochow University2
Anhui Provincial Cancer Hospital1
Anhui Provincial Hospital1
Beijing Ditan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia31
Purpura, Thrombocytopenic, Idiopathic4
Hematologic Diseases3
Purpura3
Anemia2
Coronary Artery Disease2
Hemorrhagic Stroke2
Hemostatic Disorders2
Ischemic Stroke2
Renal Insufficiency2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.